Analysed SCIENTURE HOLDINGS INC (SCNX:NASDAQ) News Sources
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
06-04-2026
yahoo.com
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
06-05-2026
yahoo.com
SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion
18-05-2026
yahoo.com
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
02-06-2026
yahoo.com
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch
09-06-2026
yahoo.com
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
18-06-2026
yahoo.com
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
22-09-2026
yahoo.com
EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
02-10-2026
yahoo.com
What is the current price of SCIENTURE HOLDINGS INC (SCNX:NASDAQ)?
The current price of SCIENTURE HOLDINGS INC (SCNX:NASDAQ) is $3.76.
SCIENTURE HOLDINGS INC (SCNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCIENTURE HOLDINGS INC (SCNX:NASDAQ) since the previous trading day is $-0.1.
SCIENTURE HOLDINGS INC (SCNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCIENTURE HOLDINGS INC (SCNX:NASDAQ) since the previous trading day is -2.5907%.
What is the most recent average sentiment score for SCIENTURE HOLDINGS INC (SCNX:NASDAQ)?
The most recent average sentiment score for SCIENTURE HOLDINGS INC (SCNX:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for SCIENTURE HOLDINGS INC (SCNX:NASDAQ)?
The most recent sentiment for SCIENTURE HOLDINGS INC (SCNX:NASDAQ) is .
SEC-8K** Filing Available For SCIENTURE HOLDINGS INC (SCNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.